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R890inherited from previous processing.
The authors focus on face images,
but the study leaves open the
possibility that the amygdala can
have similar responses to non-face
objects. Is the ‘‘holistic’’ nature of the
representation limited to faces [14]?
The dynamics of the neuronal
responses may provide further
insights regarding the computational
principles behind recognition and
object completion. What type of
computational models can give rise
to the non-intuitive responses
described in this study?
The inspiring work of Rutishauser
et al. [1] opens the doors to a rich set
of questions that deserve further
investigation.
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E-Cadherin Help Fence In Yap1Metazoan cells translate adhesive events with neighbors into anti-proliferative
signals in the nucleus. The cadherin–catenin adhesion complex has long been
suspected of playing a key role in this process, and three recent papers suggest
that it does so by modulating subcellular localization of the Hippo pathway
component Yap1.Brian S. Robinson
and Kenneth H. Moberg*
Most metazoan cells spend their
lives in close apposition with adjacent
cells and must use a variety of
communication tools to organize group
activities and set standards for
communal living. One key to a stable
cellular neighborhood is preventing
cells from over-proliferating and
crowding out neighbors. A model
of cellular crowd control has evolved,
termed ‘contact inhibition’, in which
intercellular adhesion events block
proliferation. Cancer cells arerogues that by and large fail to abide
by this rule. An understanding of the
mechanisms underlying contact
inhibition, and why certain mutations
allow cancer cells to avoid it, has,
however, remained incomplete.
Three recent papers [1–3] now help to
fill this gap by identifying E-cadherin
and a-catenin, two protein
components of the cadherin–catenin
adhesion complex, as regulators of
Yes-associated protein-1 (Yap1),
a major oncogenic component of the
Hippo tumor suppressor network. In
doing so, these groups have
illuminated what could be a centralelement of the contact inhibition
mechanism.
Yap1 and Hippo
Yap1 and its homolog TAZ
(transcriptional co-activator with
PDZ-binding motif) are the main
targets of the vertebrate Hippo
growth regulatory pathway, which
was first identified in Drosophila and
shown to be a key regulator of organ
size and tumorigenesis in other
organisms, including vertebrates [4].
Canonical Hippo signals in vertebrate
cells are transduced through two
sequentially acting sets of kinases —
Mst1 and Mst2 (Mst1/2) and Lats1 and
Lats2 (Lats1/2) — to regulate
phosphorylation of Yap1.
Phosphorylated Yap1 (p-Yap1) is
sequestered in the cytoplasm by
14-3-3 proteins [4,5], while
unphosphorylated Yap1 shuttles
into the nucleus where it interacts
with context-specific partners to
drive expression of pro-proliferative
genes.
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Figure 1. Model of E-cadherin and a-catenin regulation of Yap1.
a-Catenin and 14-3-3 proteins bind phospho-Yap1 and localize it to the cytoplasm. This a-cat-
enin–14-3-3–phospho-Yap1 complex protects Yap1 from the protein phosphatase PP2A,
which will otherwise dephosphorylate Yap1 and promote its nuclear entry. In breast epithelial
cells, E-cadherin appears to act as an adhesion receptor upstream of a-catenin to control the
a-catenin–14-3-3–phospho-Yap1 complex and thus restrain Yap1 activity. A different adhesion
receptor appears to fulfill this role in keratinocytes.
Dispatch
R891The growing list of Hippo pathway
components that are mutated in
cancers provides strong impetus to
understand its regulation. In
Drosophila epithelia, Hippo signaling
responds to extrinsic cues, such as
morphogen gradients, local
regenerative signals, cell adhesion, and
the acquisition of apicobasal polarity
[4–6]. Accordingly, key Hippo
components can be found at cell
junctions, including the atypical
cadherin Fat and the polarity protein
Crumbs [4]. Vertebrate Yap1 also
responds to cell density in culture [7]
and inhibition of Yap1 is required for
efficient contact inhibition [8]; however,
cell-surface receptors regulating
vertebrate Hippo signaling were
not particularly well understood prior
to the work summarized here. These
recent studies show that E-cadherin
and a-catenin can sequester Yap1 in
the cytoplasm where it is
transcriptionally inert, but provide
different insights into how this
mechanism operates.
Yap1 and a-Catenin
The Schlegelmilch et al. [1] and Silvis
et al. [2] groups used epidermal
keratinocytes as a model of contact
inhibition and made the shared
discovery of a direct physical
interaction between Yap1 and
a-catenin that sequesters Yap1
in the cytoplasm. The two groups
arrived at this discovery from
opposing sides of the Yap1–a-catenin
complex. Schlegelmilch et al. [1]
used immunoprecipitation/
mass-spectrometry to identify
a-catenin in a search for Yap1
regulators. This was spurred
by their observation that Yap1
is non-responsive to depletion of
the Mst1/2 or Lats1/2 kinases in
epidermal cells, implying that an
undefined Yap1 inhibitory mechanism
must predominate in this cell type.
Reciprocally, Silvis et al. [2] identified
Yap1 as a key driver of keratinocyte
overproliferation induced by a-catenin
loss. Both groups found that a-catenin
depletion or deletion in keratinocytes
relocalizes Yap1 from the cytoplasm to
the nucleus and elevates nuclear Yap1
activity. Keratinocyte overproliferation
following a-catenin loss was
suppressed by depletion of Yap1,
providing functional evidence that
Yap1 acts downstream of a-catenin.
Interestingly Schlegelmilch et al. [1]
also found that Yap1 wasnon-responsive to the depletion
of E-cadherin and/or P-cadherin,
implying that another membrane
receptor mediates contact inhibition
in this system.
a-Catenin Blocks Yap1
Dephosphorylation
The discovery of a cytoplasmic
Yap1–a-catenin complex led
Schlegelmilch et al. [1] to examine
interactions between Yap1
and 14-3-3 proteins, which bind
and retain phospho-Yap1 in the
cytoplasm [9]. This revealed that
p-Yap1, a-catenin, and 14-3-3 can
form a complex in the cytoplasm, and
that disruption of the complex
following a-catenin loss exposes
p-Yap1 to the PP2A protein
phosphatase. Subsequent
dephosphorylation drives Yap1 into
the nucleus and promotes cell
proliferation. This simple model
provides a direct link between
a-catenin and p-Yap1, and predicts
that a-catenin status is a critical
determinant of Yap1 nuclear activity,
as its loss may blunt the effect of
inhibitory kinases. Indeed,
Schlegelmilch et al. [1] found an
inverse correlation between a-cateninlevels and nuclear Yap1 protein in
squamous cell carcinoma cell lines,
indicating that dysregulation of the
Yap1–a-catenin complex contributes
to this disease. However, the data
also raise the intriguing issue of
which kinase actually phosphorylates
Yap1 in keratinocytes. If it is not the
Mst or Lats kinases, then which
kinase(s) puts the phosphate
group(s) on Yap1 that must then
be protected by a-catenin? Moreover,
if a-catenin binds Yap1, could
E-cadherin act through a-catenin to
regulate Yap1 in cell types other
than keratinocytes?
Yap1 and E-Cadherin
The third paper in the series by Kim
et al. [3] presents evidence from
non-keratinocyte breast epithelial
cells that E-cadherin acts as an
adhesion receptor that regulates Yap1
localization via catenins and the
canonical Hippo pathway. This link
is defined using beads coated with
purified E-cadherin to selectively
engage E-cadherin on the surface of
cells. While cells in situ engage in many
types of adhesive interaction with
neighbors, this system has the
advantage of parsing the downstream
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Moderate reduction of proliferation
following exposure to E-cadherin
beads could be blocked by small
interfering RNA depletion of either
a- or ß-catenin, or by depletion of the
Hippo components Merlin/NF2,
Lats1/2, and Kibra. E-cadherin
overexpression led to cytoplasmic
retention of Yap1, and this required
the E-cadherin catenin-binding
domain. Reciprocally, depletion of
ß-catenin or Lats1/2 from dense
cultures induced nuclear accumulation
and reduced phosphorylation of Yap1.
This suggests a possible tumor
suppressor role for ß-catenin that is
rather surprising considering its role in
the Wnt pathway [10]. Notably, Kim
et al. [3] found that depletion of Mst1/2
does not abrogate the anti-proliferative
effect of E-cadherin ligation,
suggesting that relocalization of Yap1
to the cytoplasm following E-cadherin
ligation occurs via a pathway requiring
the a/ß-catenins and canonical Hippo
components, but that an additional
kinase acts redundantly or in place of
Mst1/2.
Future Directions
These three studies provide
important new insight into the Hippo
pathway by identifying E-cadherin
and a-catenin as upstream regulators
of Yap1 (Figure 1). They also raise
quite a few interesting follow-on
questions. First, as E-cadherin can
associate with a-catenin, could the
Yap1–a-catenin complex be part of
a common density-sensing pathway
that begins with homotypic E-cadherin
interactions? Schlegelmilch et al. [1]
did observe cadherin peptides in
proteomic analysis of Yap1
interactors, but saw no obvious
change in Yap1 reporters following
depletion of E-cadherin or ß-catenin
depletion from cultured keratinocytes.
However calcium depletion, which
disrupts E-cadherin homotypic
interactions, did trigger redistribution
of Yap1 into the nucleus. The inability
of E-cadherin depletion to robustly
activate Yap1 in keratinocytes thus
raises the interesting possibility
that the Yap1–a-catenin complex
is regulated by adhesion inputs
in a cell-type-specific manner, with
the emphasis on E-cadherin in breast
epithelial cells and on other
transmembrane proteins in
keratinocytes. Thus, a second
important issue is whether multipleadhesion complexes serve
overlapping roles upstream of
Yap1–a-Catenin. Crb3, the vertebrate
homolog of fly Crumbs, regulates
density-dependent growth through
Yap1/TAZ and may be a candidate for
this role [7]. Fly Crumbs controls
Hippo signals by interacting with the
cytoskeletal linker protein Expanded,
which localizes to apical adherens
junctions [11–14] and binds Merlin
and Kibra [15]. Vertebrate Merlin/NF2
in turn promotes adherens junction
formation and binds to a-catenin in
keratinocytes [16]. As this
Merlin/NF2–a-catenin complex also
includes the Par3 protein, apical
polarity complexes could provide
additional input into a-catenin
regulation. Yap1 can also be found
in a complex with the tight junction
proteins Amot and ZO-2 [17], and
Amot is required to recruit Yap1 to the
tight junctions and for contact
inhibition in cultured MDCK cells [18].
Yap1/TAZ proteins may then receive
regulatory input from tight junction
and polarity complexes, as well as from
proteins at the adherens junction.
Finally, in what may be a case of
turnabout being fair play, Crumbs,
Expanded and the E-cadherin
homolog Shotgun can be induced in
fly epithelial cells by mutations that
activate the Yap1 ortholog Yki [19,20]
(and see [7,14]), suggesting an
inhibitory feedback loop in which
decreased Hippo signals upregulate
junctional proteins. The potential
complexity of this network, and the role
of a-catenin in it, will surely keep
researchers hard at work for some time
unraveling additional molecular links
between cellular adhesion and Hippo
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